Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Research and Practice in Thrombosis and Haemostasis|October 10, 2025
Thromboembolism and bleeding in newly diagnosed multiple myeloma: rates, risk profile, and patterns of thromboprophylaxisLea Vospernik, Hermine Agis, Cihan Ay, et al.
European Journal of Clinical Investigation|May 18, 2012
Overexpression of G protein-coupled receptor 5D in the bone marrow is associated with poor prognosis in patients with multiple myelomaJohanna Atamaniuk, Andreas Gleiss, Edit Porpaczy, et al.
European Journal of Haematology|April 1, 2018
Impact of white blood cells on thrombotic risk in patients with optimized platelet count in essential thrombocythemiaVeronika Buxhofer-Ausch, Michael Steurer, Siegfried Sormann, et al.
Cancers|August 23, 2020
Myelomonocytic Skewing In Vitro Discriminates Subgroups of Patients with Myelofibrosis with A Different Phenotype, A Different Mutational Profile and Different PrognosisKlaus Geissler, Bettina Gisslinger, Eva Jäger, et al.
Leukemia Research|May 3, 2005
High dose intermittent ARA-C (HiDAC) for consolidation of patients with de novo AML: a single center experienceAlexandra Böhm, Maria Piribauer, Friedrich Wimazal, et al.
Blood|October 29, 2008
Thalidomide-dexamethasone compared with melphalan-prednisolone in elderly patients with multiple myelomaHeinz Ludwig, Roman Hajek, Elena Tóthová, et al.
British Journal of Haematology|June 26, 2020
Real-world non-interventional long-term post-authorisation safety study of ruxolitinib in myelofibrosisFiorenza Barraco, Richard Greil, Raoul Herbrecht, et al.
Scientific Reports|February 24, 2019
The circulating form of neprilysin is not a general biomarker for overall survival in treatment-naïve cancer patientsNoemi Pavo, Henrike Arfsten, Anna Cho, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 9, 2010
Light chain-induced acute renal failure can be reversed by bortezomib-doxorubicin-dexamethasone in multiple myeloma: results of a phase II studyHeinz Ludwig, Zdenek Adam, Roman Hajek, et al.
European Journal of Heart Failure|March 24, 2020
Increased resting heart rate and prognosis in treatment-naïve unselected cancer patients: results from a prospective observational studyMarkus S Anker, Maria K Frey, Georg Goliasch, et al.
Pageof 15